51. Vrednotenje imunske modulacije in učinkovitosti agonista receptorja EP4 in monoklonskih protiteles in vitroTijana Markovič, 2018, doctoral dissertation Keywords: zdravilne učinkovine, imunomodulatorno delovanje, vrednotenje, metode, limfoblastoidne celične linije, receptor EP4, agonisti, limfom, monoklonska protitelesa, levkemija celic B Full text (file, 4,22 MB) |
52. Polymorphism in gene for ABCC2 transporter predicts methotrexate drug survival in patients with psoriasisJasna Grželj, Maruška Marovt, Pij B. Marko, Irena Mlinarič-Raščan, Tanja Gmeiner, Alenka Šmid, 2021, original scientific article Keywords: psoriasis, drug survival, methotrexate, pharmacogenetics Full text (file, 865,71 KB) This document has more files! More... |
53. Folate insufficiency due to MTHFR deficiency is bypassed by 5-methyltetrahydrofolateMaša Vidmar Golja, Alenka Šmid, Nataša Karas Kuželički, Jurij Trontelj, Ksenija Geršak, Irena Mlinarič-Raščan, 2020, original scientific article Keywords: MTHFR, 5, 10-methylenetetrahydrofolate reductase polymorphisms, folate supplementation, folic acid, FA, 5-methyl-tetrahydrofolate, 5-Me-THF Full text (file, 2,21 MB) This document has more files! More... |
54. Iskanje modulatorjev programirane smrti celic kronične limfocitne levkemijeSanja Nabergoj, 2021, doctoral dissertation Keywords: receptor EP4, prostaglandinski receptorji, receptor NOD2, modelna celična linija MEC-1, protitumorno delovanje, terapija bolnikov, kronična limfocitna levkemija Full text (file, 5,74 MB) |
55. Farmakogenomsko vrednotenje dovzetnosti na tiopurineDunja Urbančič, 2018, doctoral dissertation Keywords: farmakogenomika, tiopurini, tiopurin-S-metiltransferaza, farmakogenomika tiopurinov, citotoksičnost interakcij, zdravilne učinkovine, odziv na tiopurine, disertacije, biološka zdravila
|
56. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cellsDamjan Avsec, Alma Tana Jakoš Djordjevič, Maša Kandušer, Helena Podgornik, Matevž Škerget, Irena Mlinarič-Raščan, 2021, original scientific article Keywords: chronic lymphocytic leukemia, autophagy, AMPK/ULK1, venetoclax, drug resistance, targeted therapy Full text (file, 5,50 MB) This document has more files! More... |
57. Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapySanja Nabergoj, Irena Mlinarič-Raščan, Žiga Jakopin, 2019, review article Keywords: adjuvants, cancer immunotherapy, immunotherapeutics, NOD1 agonists, NOD1 antagonists, NOD2 agonists, NOD2 antagonists Full text (file, 2,15 MB) This document has more files! More... |
|
|
|